Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2003 Apr;74(4):423–426. doi: 10.1136/jnnp.74.4.423

Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease

K Hamada 1, M Hirayama 1, H Watanabe 1, R Kobayashi 1, H Ito 1, T Ieda 1, Y Koike 1, G Sobue 1
PMCID: PMC1738357  PMID: 12640054

Abstract

Objectives: To elucidate the factors associated with severity of cardiac sympathetic nerve involvement in idiopathic Parkinson's disease (PD).

Methods: 123I-metaiodobenzylguanidine uptake was examined in 88 patients with PD. The ratio of the uptake in the heart (H) to that in the mediastinum (M) (the H/M ratio) was calculated and correlated with age at onset, age at examination, and disease severity and duration. Twenty five healthy people were also examined as a control.

Results: There was a mild but significant negative correlation between H/M ratio and age at onset (early, r = -0.33, p = 0.002; delayed, r = -0.34, p = 0.001) and between Hoehn and Yahr (H-Y) stage (early, r = -0.30, p = 0.006; delayed, r = -0.32, p = 0.003). There was no significant correlation between disease duration and H/M ratio. When patients with PD were classified into four subgroups on the basis of age at onset (> 62 or < 62 years) and disease severity (H-Y > III or H-Y ⩽ II), the median H/M ratio of the older and more severe group was significantly lower than that of the younger and less severe group (p = 0.005).

Conclusion: This study suggests that late onset, high severity PD is associated with myocardial sympathetic dysfunction.

Full Text

The Full Text of this article is available as a PDF (192.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apaydin Hulya, Ahlskog J. Eric, Parisi Joseph E., Boeve Bradley F., Dickson Dennis W. Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response. Arch Neurol. 2002 Jan;59(1):102–112. doi: 10.1001/archneur.59.1.102. [DOI] [PubMed] [Google Scholar]
  2. Blin J., Dubois B., Bonnet A. M., Vidailhet M., Brandabur M., Agid Y. Does ageing aggravate parkinsonian disability? J Neurol Neurosurg Psychiatry. 1991 Sep;54(9):780–782. doi: 10.1136/jnnp.54.9.780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Braune S., Reinhardt M., Bathmann J., Krause T., Lehmann M., Lücking C. H. Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure. Acta Neurol Scand. 1998 May;97(5):307–314. doi: 10.1111/j.1600-0404.1998.tb05958.x. [DOI] [PubMed] [Google Scholar]
  4. Braune S., Reinhardt M., Schnitzer R., Riedel A., Lücking C. H. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology. 1999 Sep 22;53(5):1020–1025. doi: 10.1212/wnl.53.5.1020. [DOI] [PubMed] [Google Scholar]
  5. Daniel S. E., Lees A. J. Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm Suppl. 1993;39:165–172. [PubMed] [Google Scholar]
  6. Druschky A., Hilz M. J., Platsch G., Radespiel-Tröger M., Druschky K., Kuwert T., Neundörfer B. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci. 2000 Apr 1;175(1):3–12. doi: 10.1016/s0022-510x(00)00279-3. [DOI] [PubMed] [Google Scholar]
  7. Goldstein D. S., Holmes C. S., Dendi R., Bruce S. R., Li S-T. Orthostatic hypotension from sympathetic denervation in Parkinson's disease. Neurology. 2002 Apr 23;58(8):1247–1255. doi: 10.1212/wnl.58.8.1247. [DOI] [PubMed] [Google Scholar]
  8. Hakusui S., Yasuda T., Yanagi T., Tohyama J., Hasegawa Y., Koike Y., Hirayama M., Takahashi A. A radiological analysis of heart sympathetic functions with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst. 1994 Sep;49(1):81–84. doi: 10.1016/0165-1838(94)90023-x. [DOI] [PubMed] [Google Scholar]
  9. Hirayama M., Hakusui S., Koike Y., Ito K., Kato T., Ikeda M., Hasegawa Y., Takahashi A. A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst. 1995 Jun 25;53(2-3):230–234. doi: 10.1016/0165-1838(95)00002-f. [DOI] [PubMed] [Google Scholar]
  10. Hurtig H. I., Trojanowski J. Q., Galvin J., Ewbank D., Schmidt M. L., Lee V. M., Clark C. M., Glosser G., Stern M. B., Gollomp S. M. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology. 2000 May 23;54(10):1916–1921. doi: 10.1212/wnl.54.10.1916. [DOI] [PubMed] [Google Scholar]
  11. Iwanaga K., Wakabayashi K., Yoshimoto M., Tomita I., Satoh H., Takashima H., Satoh A., Seto M., Tsujihata M., Takahashi H. Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. Neurology. 1999 Apr 12;52(6):1269–1271. doi: 10.1212/wnl.52.6.1269. [DOI] [PubMed] [Google Scholar]
  12. Iwasa K., Nakajima K., Yoshikawa H., Tada A., Taki J., Takamori M. Decreased myocardial 123I-MIBG uptake in Parkinson's disease. Acta Neurol Scand. 1998 May;97(5):303–306. doi: 10.1111/j.1600-0404.1998.tb05957.x. [DOI] [PubMed] [Google Scholar]
  13. Koike Y., Takahashi A. Autonomic dysfunction in Parkinson's disease. Eur Neurol. 1997;38 (Suppl 2):8–12. doi: 10.1159/000113470. [DOI] [PubMed] [Google Scholar]
  14. Levy G., Tang M. X., Cote L. J., Louis E. D., Alfaro B., Mejia H., Stern Y., Marder K. Motor impairment in PD: relationship to incident dementia and age. Neurology. 2000 Aug 22;55(4):539–544. doi: 10.1212/wnl.55.4.539. [DOI] [PubMed] [Google Scholar]
  15. Levy Gilberto, Schupf Nicole, Tang Ming-Xin, Cote Lucien J., Louis Elan D., Mejia Helen, Stern Yaakov, Marder Karen. Combined effect of age and severity on the risk of dementia in Parkinson's disease. Ann Neurol. 2002 Jun;51(6):722–729. doi: 10.1002/ana.10219. [DOI] [PubMed] [Google Scholar]
  16. Mäntysaari M., Kuikka J., Mustonen J., Tahvanainen K., Vanninen E., Länsimies E., Uusitupa M. Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine. Diabetes. 1992 Sep;41(9):1069–1075. doi: 10.2337/diab.41.9.1069. [DOI] [PubMed] [Google Scholar]
  17. Niimi Y., Ieda T., Hirayama M., Koike Y., Sobue G., Hasegawa Y., Takahashi A. Clinical and physiological characteristics of autonomic failure with Parkinson's disease. Clin Auton Res. 1999 Jun;9(3):139–144. doi: 10.1007/BF02281627. [DOI] [PubMed] [Google Scholar]
  18. Oliveri R. L., Zappia M., Annesi G., Bosco D., Annesi F., Spadafora P., Pasqua A. A., Tomaino C., Nicoletti G., Pirritano D. The parkin gene is not involved in late-onset Parkinson's disease. Neurology. 2001 Jul 24;57(2):359–362. doi: 10.1212/wnl.57.2.359. [DOI] [PubMed] [Google Scholar]
  19. Orimo S., Ozawa E., Nakade S., Sugimoto T., Mizusawa H. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):189–194. doi: 10.1136/jnnp.67.2.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Orimo S., Ozawa E., Oka T., Nakade S., Tsuchiya K., Yoshimoto M., Wakabayashi K., Takahashi H. Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA. Neurology. 2001 Sep 25;57(6):1140–1141. doi: 10.1212/wnl.57.6.1140. [DOI] [PubMed] [Google Scholar]
  21. Satoh A., Serita T., Seto M., Tomita I., Satoh H., Iwanaga K., Takashima H., Tsujihata M. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value. J Nucl Med. 1999 Mar;40(3):371–375. [PubMed] [Google Scholar]
  22. Stanton M. S., Tuli M. M., Radtke N. L., Heger J. J., Miles W. M., Mock B. H., Burt R. W., Wellman H. N., Zipes D. P. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine. J Am Coll Cardiol. 1989 Nov 15;14(6):1519–1526. doi: 10.1016/0735-1097(89)90391-4. [DOI] [PubMed] [Google Scholar]
  23. Takatsu H., Nishida H., Matsuo H., Watanabe S., Nagashima K., Wada H., Noda T., Nishigaki K., Fujiwara H. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med. 2000 Jan;41(1):71–77. [PubMed] [Google Scholar]
  24. Taki J., Nakajima K., Hwang E. H., Matsunari I., Komai K., Yoshita M., Sakajiri K., Tonami N. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp. Eur J Nucl Med. 2000 May;27(5):566–573. doi: 10.1007/s002590050544. [DOI] [PubMed] [Google Scholar]
  25. Tsuchimochi S., Tamaki N., Tadamura E., Kawamoto M., Fujita T., Yonekura Y., Konishi J. Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med. 1995 Jun;36(6):969–974. [PubMed] [Google Scholar]
  26. Watanabe H., Ieda T., Katayama T., Takeda A., Aiba I., Doyu M., Hirayama M., Sobue G. Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):781–783. doi: 10.1136/jnnp.70.6.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Watanabe H., Misu K., Hirayama M., Hattori N., Yoshihara T., Doyu M., Sobue G. Low cardiac 123I-MIBG uptake in late-onset familial amyloid polyneuropathy type I (TTR Met30). J Neurol. 2001 Jul;248(7):627–629. doi: 10.1007/s004150170146. [DOI] [PubMed] [Google Scholar]
  28. Wieland D. M., Wu J., Brown L. E., Mangner T. J., Swanson D. P., Beierwaltes W. H. Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med. 1980 Apr;21(4):349–353. [PubMed] [Google Scholar]
  29. Yoshita M. Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. J Neurol Sci. 1998 Feb 18;155(1):60–67. doi: 10.1016/s0022-510x(97)00278-5. [DOI] [PubMed] [Google Scholar]
  30. Yoshita M., Hayashi M., Hirai S. Decreased myocardial accumulation of 123I-meta-iodobenzyl guanidine in Parkinson's disease. Nucl Med Commun. 1998 Feb;19(2):137–142. doi: 10.1097/00006231-199802000-00007. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES